Akademik Veri Yönetim Sistemi
Thoracic research and practice, cilt.27, sa.1, ss.75-76, 2026 (ESCI, Scopus, TRDizin)
Bronchiectasis demonstrates a significant discrepancy between its high prevalence and the limited evidence base. Patient registries, both national and international, are key to collecting comprehensive data. However, the cost-effectiveness of this approach remains a subject of ongoing debate.1 In the opinion of the authors of this editorial, despite the significant costs and effort involved in establishing such registries, they are justified—provided that certain key characteristics are met. The registry must be sufficiently comprehensive in capturing relevant variables to avoid missing critical data that could impede meaningful research, particularly in areas such as therapeutic interventions, comorbidities, microbiological findings, and prognostic factors.